Thursday, January 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Trustco Bank Declares Quarterly Dividend of 36 Cents per Share

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Finance_Credit
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Trustco Bank (NASDAQ: TRST) has recently declared a quarterly dividend of 36 cents per share to be paid out on April 01, 2024. The ex-dividend date is set for Thursday, which means the stock is expected to open 36 cents lower on that day to adjust for the dividend payout.

Shareholders who hold TRST as of the end of Wednesday’s trading session will qualify to receive the dividend. Trustco Bank Corp NY (TRST) has a history of paying dividends ranging from $0.06813 to $0.36 per share quarterly. The company’s last ex-dividend date was on November 30, 2023, where it paid out $0.36 per share.

Investors have the option to reinvest these dividends into the stock or use the payment in other ways. To keep track of companies distributing dividends, investors can utilize resources like TipRanks. Stay informed and make the most of your investment opportunities.

TRST Stock Price Declines on February 26, 2024: Opportunity for Value Investors?

On February 26, 2024, TRST stock experienced a decline in its price, closing at $27.57, which was $0.33 lower than the previous market close. This represents a 1.18% drop in the stock price for the day. Despite the decrease in price during regular trading hours, the stock remained unchanged in after-hours trading. This could indicate that investors are taking a cautious approach towards TRST, possibly waiting for more information or market conditions to change before making any significant moves. The fact that TRST is trading near the bottom of its 52-week range suggests that the stock may be undervalued at its current price. Overall, the performance of TRST stock on February 26, 2024, reflects a slight decline in price but with potential opportunities for value investors.

TRST Stock Performance: Revenue Up, Net Income Down – February 26, 2024 Review

On February 26, 2024, TRST stock experienced mixed performances as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, TRST’s total revenue stood at $244.00 million for the past year, representing an 18.45% increase compared to the previous year. However, total revenue remained flat at $63.13 million for the fourth quarter, indicating no growth from the previous quarter.

In terms of net income, TRST reported a net income of $58.65 million for the past year, which was a 22.05% decrease from the previous year. The net income for the fourth quarter was $9.85 million, showing a 32.92% decrease from the previous quarter. This decline in net income could be a cause for concern for investors as it indicates a decrease in profitability for the company.

Furthermore, TRST’s earnings per share (EPS) also experienced a decline. The EPS for the past year was $3.08, marking a 21.67% decrease from the previous year. The EPS for the fourth quarter was $0.52, showing a 32.93% decrease from the previous quarter. This decrease in EPS could be attributed to the decline in net income and could impact investor confidence in the company’s future earnings potential.

Overall, TRST stock performances on February 26, 2024, were mixed as the company reported a strong increase in total revenue for the past year but a decline in net income and EPS. Investors may want to closely monitor TRST’s financial performance in the coming quarters to assess whether these declines are temporary or indicative of a larger issue within the company.

Tags: TRST
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Short Interest in Crown Holdings NYSE CCK Declines by 83

From Novice to Expert: Navigating the Cryptocurrency Learning Curve

Title Milestone Pharmaceuticals Inc NASDAQ MIST Surges on Plans to Resubmit NDA for Etripamil

Analyst Reiterates Positive Outlook on Ocular Therapeutix with Increased Price Target

Recommended

Rocket Lab USA Stock

Rocket Lab Shares Pull Back Following Record Rally

4 weeks ago
Adobe Stock

Adobe’s $3 Billion AI Ambition: A Failed Bid for Video Dominance

3 months ago
European Lithium Stock

European Lithium Faces Major Regulatory Hurdle in Austria

2 months ago
Evgo Stock

EVgo Shares Surge on Major Charging Network Milestone

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

IBM’s Strategic Pivot: AI Ambitions Face Earnings Test

Chevron Navigates Operational Halt and Strategic Shifts

Metaplanet’s Stock Feels the Strain of Bitcoin’s Decline

Bitcoin Navigates Volatile Terrain Amid Institutional Shifts

Solana Defies Market Downturn with Unprecedented Staking Activity

Nvidia’s AI Ambition Receives Fresh Validation from Industry Leaders

Trending

Newmont Mining Stock
Analysis

Newmont’s Stock Surge Faces Operational Headwinds

by Felix Baarz
January 22, 2026
0

Shares of Newmont Mining are trading near unprecedented levels, propelled by a historic rally in the underlying...

Arafura Stock

Arafura Resources: The Nolan Project’s Strategic Ascent

January 22, 2026
Bionxt Solutions Stock

BioNxt Solutions Reports Significant Preclinical Advance for MS Treatment

January 22, 2026
IBM Stock

IBM’s Strategic Pivot: AI Ambitions Face Earnings Test

January 22, 2026
Chevron Stock

Chevron Navigates Operational Halt and Strategic Shifts

January 22, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Newmont’s Stock Surge Faces Operational Headwinds
  • Arafura Resources: The Nolan Project’s Strategic Ascent
  • BioNxt Solutions Reports Significant Preclinical Advance for MS Treatment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com